欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/0739/001
药品名称Gaviscon Peppermint Chewable Tablets Sodium alginate
活性成分
    • Sodium alginate carbonate 250.0 mg
剂型Chewable tablet
上市许可持有人Reckitt Benckiser Ireland Ltd, 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Gaviscon Mint Kautabletten
    • Greece (GR)
    • Poland (PL)
      Gaviscon o smaku mięty TAB
    • Cyprus (CY)
    • Romania (RO)
      Gaviscon mentol comprimate masticabile
    • Germany (DE)
    • Denmark (DK)
    • Iceland (IS)
    • France (FR)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Hungary (HU)
    • Bulgaria (BG)
    • Slovakia (SK)
    • Slovenia (SI)
    • Czechia (CZ)
许可日期2008/04/05
最近更新日期2025/07/23
药物ATC编码
    • A02BX13 alginic acid
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase